Network-based approach to prediction and population-based validation of in silico drug repurposing
Repurposing approved drugs could accelerate treatment options for various diseases. Here, the authors use network proximity of disease gene products and drug targets in the human protein interactome to identify drug-disease associations for cardiovascular disease, and validate these using longitudin...
Guardado en:
Autores principales: | Feixiong Cheng, Rishi J. Desai, Diane E. Handy, Ruisheng Wang, Sebastian Schneeweiss, Albert-László Barabási, Joseph Loscalzo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/264d3bc2952944739e5a0650a3d519eb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A genome-wide positioning systems network algorithm for in silico drug repurposing
por: Feixiong Cheng, et al.
Publicado: (2019) -
Network-based in silico drug efficacy screening
por: Emre Guney, et al.
Publicado: (2016) -
Network-based prediction of drug combinations
por: Feixiong Cheng, et al.
Publicado: (2019) -
Publisher Correction: Network-based prediction of drug combinations
por: Feixiong Cheng, et al.
Publicado: (2019) -
A Maximum Flow-Based Approach to Prioritize Drugs for Drug Repurposing of Chronic Diseases
por: Md. Mohaiminul Islam, et al.
Publicado: (2021)